InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,487.03
(
0.25%
)
US TECH 100
19,430.40
(
0.14%
)
Dow Jones
38,834.86
(
0.15%
)
Brent Oil
84.70
(
-0.11%
)
Bitcoin
64,904.19
(
-0.36%
)
Post# of 252255
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

swampboots

Send PM Follow Ignore
Followers 183
Posts 30024
Boards Moderated 3
Alias Born 07/09/2003

swampboots

Member Level

Re: None

Thursday, 10/27/2022 9:48:33 AM

Thursday, October 27, 2022 9:48:33 AM

Post# of 252255
EPIX: New method for blocking androgen receptor signaling which may be main driver of prostate cancer progression showed progress in preclinical setting, and gave stock a double yesterday.

https://www.streetinsider.com/Corporate+News/ESSA+Pharma+%28EPIX%29+Presents+Preclinical+Data+for+its+First+Generation+Androgen+Receptor+N-Terminal+Domain+Degrader/20750059.html
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up